Deep phenotyping of peripheral tissue in Parkinson’s
Skin cells have been used to characterize specific cellular problems in people with Parkinson’s, in a new approach that may help match them to particular drugs that may work best for them.
Skin cells have been used to characterize specific cellular problems in people with Parkinson’s, in a new approach that may help match them to particular drugs that may work best for them.
A new preclinical study has shown that LRRK2 inhibition in an animal model of Parkinson’s can improve lysosomal health and reduce alpha synuclein accumulation in dopaminergic neurons.